REG-Worldwide Healthcare: Director/PDMR Shareholding

Worldwide Healthcare TrustAnnouncement

31/01/2023 17:45

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 1                         Details of the person discharging managerial responsibilities / person closely associated                                                                                                             
 a)                        Name                                                                                               Joanne Parfrey                                                                                     
 2                         Reason for the notification                                                                                                                                                                           
 a)                        Position/status                                                                                    Non-executive Director                                                                             
 b)                        Initial notification /Amendment                                                                    Initial notification                                                                               
 3                         Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor                                                                                         
 a)                        Name                                                                                               Worldwide Healthcare Trust PLC                                                                     
 b)                        LEI                                                                                                5493003YBCY4W1IMJU04                                                                               
 4                         Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted     
 a)                        Description of the financial instrument, type of instrument  Identification code                   Ordinary 25p shares   GB0003385308                                                                 
 b)                        Nature of the transaction                                                                          Acquisition of shares                                                                              
 c)                        Price(s) and volume(s)                                                                                                                                                                                
 Price(s)                  Volume(s)                                                                                          
 3,120.00 pence per share  2,000                                                                                              
 d)                        Aggregated information   - Aggregated volume   - Price                                             2,000 ordinary 25p shares   3,120.00 pence per share                                               
 e)                        Date of the transaction                                                                            31 January 2023                                                                                    
 f)                        Place of the transaction                                                                           London Stock Exchange (XLON)                                                                       

Name of authorised official of issuer responsible for making notification:

Mark Pope, for and on behalf of Frostrow Capital LLP

Company Secretary to WORLDWIDE HEALTHCARE TRUST PLC



Copyright (c) 2023 PR Newswire Association,LLC. All Rights Reserved